102 related articles for article (PubMed ID: 29632908)
21. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
[TBL] [Abstract][Full Text] [Related]
22. 5-Fluorouracil enteric-coated nanoparticles for improved apoptotic activity and therapeutic index in treating colorectal cancer.
Tummala S; Kuppusamy G; Satish Kumar MN; Praveen TK; Wadhwani A
Drug Deliv; 2016 Oct; 23(8):2902-2910. PubMed ID: 26634385
[TBL] [Abstract][Full Text] [Related]
23. Daunorubicin-Loaded DNA Origami Nanostructures Circumvent Drug-Resistance Mechanisms in a Leukemia Model.
Halley PD; Lucas CR; McWilliams EM; Webber MJ; Patton RA; Kural C; Lucas DM; Byrd JC; Castro CE
Small; 2016 Jan; 12(3):308-20. PubMed ID: 26583570
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and anticancer activity of some 5-fluoro-2'-deoxyuridine phosphoramidates.
Lewandowska M; Ruszkowski P; Chojnacka K; Kleczewska N; Hoffmann M; Kacprzak K; Celewicz L
Bioorg Med Chem; 2016 May; 24(10):2330-41. PubMed ID: 27073055
[TBL] [Abstract][Full Text] [Related]
25. Potentiation of the antitumor action of 5-fluorouracil with 5-ethyl-2'-deoxyuridine in human colorectal tumor xenografts.
Kopper L; Magyarosy E; Jeney A; Lapis K; Szabolcs A; Otvös L
Oncology; 1984; 41(3):155-8. PubMed ID: 6328393
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of two fluorouracil administration regimens for colorectal cancer.
Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
[TBL] [Abstract][Full Text] [Related]
27. Disulfiram-mediated inhibition of NF-kappaB activity enhances cytotoxicity of 5-fluorouracil in human colorectal cancer cell lines.
Wang W; McLeod HL; Cassidy J
Int J Cancer; 2003 Apr; 104(4):504-11. PubMed ID: 12584750
[TBL] [Abstract][Full Text] [Related]
28. Reversal Effects of Bound Polyphenol from Foxtail Millet Bran on Multidrug Resistance in Human HCT-8/Fu Colorectal Cancer Cell.
Lu Y; Shan S; Li H; Shi J; Zhang X; Li Z
J Agric Food Chem; 2018 May; 66(20):5190-5199. PubMed ID: 29730933
[TBL] [Abstract][Full Text] [Related]
29. Chronic exposure of colorectal cancer cells in culture to fluoropyrimidine analogs induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance.
Subbarayan PR; Sarkar M; Nelson G; Benitez E; Singhal S; Ardalan B
Anticancer Res; 2010 Apr; 30(4):1149-56. PubMed ID: 20530421
[TBL] [Abstract][Full Text] [Related]
30. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer.
Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T
Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876
[TBL] [Abstract][Full Text] [Related]
31. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
32. DNA origami as an in vivo drug delivery vehicle for cancer therapy.
Zhang Q; Jiang Q; Li N; Dai L; Liu Q; Song L; Wang J; Li Y; Tian J; Ding B; Du Y
ACS Nano; 2014 Jul; 8(7):6633-43. PubMed ID: 24963790
[TBL] [Abstract][Full Text] [Related]
33. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
34. In vitro cytotoxicity and in vivo efficacy of 5-fluorouracil-loaded enteric-coated PEG-cross-linked chitosan microspheres in colorectal cancer therapy in rats.
Ganguly K; Kulkarni AR; Aminabhavi TM
Drug Deliv; 2016 Oct; 23(8):2838-2851. PubMed ID: 26530807
[TBL] [Abstract][Full Text] [Related]
35. Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells.
Li XL; Wang CZ; Mehendale SR; Sun S; Wang Q; Yuan CS
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1097-104. PubMed ID: 19277659
[TBL] [Abstract][Full Text] [Related]
36. CD133(-) cells, derived from a single human colon cancer cell line, are more resistant to 5-fluorouracil (FU) than CD133(+) cells, dependent on the β1-integrin signaling.
Hongo K; Tanaka J; Tsuno NH; Kawai K; Nishikawa T; Shuno Y; Sasaki K; Kaneko M; Hiyoshi M; Sunami E; Kitayama J; Takahashi K; Nagawa H
J Surg Res; 2012 Jun; 175(2):278-88. PubMed ID: 21601882
[TBL] [Abstract][Full Text] [Related]
37. [Recent advance in chemotherapy for advanced colorectal cancer].
Aiba K
Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
[TBL] [Abstract][Full Text] [Related]
38. Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine as an effector in radiation-activated prodrugs.
Shibamoto Y; Mimasu Y; Tachi Y; Hatta H; Nishimoto S
J Chemother; 2002 Aug; 14(4):390-6. PubMed ID: 12420858
[TBL] [Abstract][Full Text] [Related]
39. The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.
Ojima E; Inoue Y; Watanabe H; Hiro J; Toiyama Y; Miki C; Kusunoki M
Oncol Rep; 2006 Nov; 16(5):1085-91. PubMed ID: 17016597
[TBL] [Abstract][Full Text] [Related]
40. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.
Folprecht G; Köhne CH
Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
